Vasta Platform
VSTA
$3.74
Share price
-0.27%
Change (1 day)
-1.58%
Change (1 year)
Categories
P/S ratio for Vasta Platform (VSTA)
P/S ratio as of April 2024 (TTM): 1.10
According to Vasta Platform's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.09921. At the end of 2023 the company had a P/S ratio of 1.21.
P/S ratio history for Vasta Platform from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.21 | -9.33% |
| 2022 | 1.34 | -33.93% |
| 2021 | 2.02 | -68.19% |
| 2020 | 6.36 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Verastem Oncology
VSTM | N/A | N/A | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | 8.22 | 647.50% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 0.0952 | -91.34% | 🇺🇸 USA |